Overlapping of lamivudine and adefovir before switching to adefovir monotherapy in lamivudine resistant chronic hepatitis B: Is it necessary?

被引：1
|
作者：
Lee, H. I.
Lee, J. H.
Tak, W. Y.
Hwang, J. S.
Bae, S. H.
Lee, T. H.
Lee, C. K.
Baik, S. K.
Kim, M. Y.
Park, N. H.
Ryu, S. H.
Gwak, G. Y.
Koh, K. C.
Paik, S. W.
Yoo, B. C.
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea
[2] Kyungpook Natl Univ Hosp, Dept Med, Taegu, South Korea
[3] Keimyung Univ, Dongsan Med Ctr, Dept Med, Taegu, South Korea
[4] Catholic Univ Korea, Kangnam St Mary Hosp, Dept Med, Seoul, South Korea
[5] Konyang Univ, Coll Med, Dept Med, Taejon, South Korea
[6] Natl Hlth Insurance Corp, Dept Med, Goyang, South Korea
[7] Yonsei Univ, Coll Med, Dept Med, Wonju, South Korea
[8] Univ Ulsan Hosp, Dept Med, Ulsan, South Korea
[9] Univ Inje, Seoul Paik Hosp, Coll Med, Dept Med, Seoul, South Korea
来源：
JOURNAL OF HEPATOLOGY | 2007年 / 46卷
关键词：
D O I：
10.1016/S0168-8278(07)62101-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
503
引用
收藏
页码：S191 / S192
页数：2
相关论文
共 50 条
  • [21] Rescue therapy for lamivudine-resistant chronic hepatitis B: Comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapy
    Kim, Hong Joo
    Park, Jung Ho
    Park, Dong Il
    Cho, Yong Kyun
    Sohn, Chong Il
    Jeon, Woo Kyu
    Kim, Byung Ik
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (08) : 1374 - 1380
  • [22] TREATMENT RESPONSE OF COMBINED LAMIVUDINE PLUS ADEFOVIR DIPIVOXIL OR ENTECAVIR MONOTHERAPY IN ADEFOVIR-RESISTANT CHRONIC HEPATITIS B PATIENTS
    Chen, Chien-Hung
    Wang, Jing-Houng
    Lu, Sheng-Nan
    Hu, Tsung-Hui
    Hung, Chao-Hung
    Lee, Chuan-Mo
    HEPATOLOGY, 2010, 52 (04) : 551A - 551A
  • [23] Lamivudine and Adefovir Combination Therapy in Lamivudine Resistant HBeAg Positive Chronic Hepatitis B Patients
    Lee, H. S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A190 - A190
  • [24] Telbivudine Plus Adefovir Versus Lamivudine Plus Adefovir for Lamivudine-Resistant Chronic Hepatitis B: TeSLA Randomized Trial
    Kim, Tae Hyung
    Kim, Minkoo
    Yim, Hyung Joon
    Suh, Sang Jun
    Jung, Young Kul
    Seo, Yeon Seok
    Um, Soon Ho
    Lee, Jung Il
    Lee, Sae Hwan
    Kim, Sang Gyun
    Kim, In Hee
    Kim, Hyoung Su
    Cho, Eun Young
    Kim, Tae Yeob
    Hwang, Seong Gyu
    HEPATITIS MONTHLY, 2021, 21 (11)
  • [25] Adefovir dipivoxil plus lamivudine combination treatment is superior to adefovir dipivoxil monotherapy in lamivudine-resistant hepatitis B E antigen-negative chronic hepatitis B patients
    Vassiliadis, Themistoklis
    Giouleme, Olga
    Koumerkeridis, Georgios
    Charalompos, Koumaras
    Tziomalos, Konstantinos
    Patsiaoura, Koliopi
    Mpoumponaris, Alexander
    Gkisakis, Dimitrios
    Theodoropoulos, Konstantinos
    Grammatikos, Nikolaos
    Panderi, Athanasia
    Nikolaidis, Nikolaos
    Evgenidis, Nikolaos
    HEPATOLOGY, 2007, 46 (04) : 662A - 663A
  • [26] Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B
    Dai, Chia-Yen
    Chuang, Wan-Long
    Hsieh, Ming-Yen
    Lee, Li-Po
    Huang, Jee-Fu
    Hou, Nai-Jen
    Lin, Zu-Yau
    Chen, Shinn-Cherng
    Hsieh, Ming-Yuh
    Wang, Liang-Yen
    Tsai, Jun-Fa
    Chang, Wen-Yu
    Yu, Ming-Lung
    ANTIVIRAL RESEARCH, 2007, 75 (02) : 146 - 151
  • [27] The Feasibility of Discontinuing Lamivudine in Lamivudine-Resistant Chronic Hepatitis B Patients on Lamivudine and Adefovir Combination Therapy
    Chung, Seong Min
    Byoun, Young-Sang
    Kim, Hee-Sup
    Jang, Eun Sun
    Kim, Jin-Wook
    Jeong, Sook-Hyang
    INTERVIROLOGY, 2014, 57 (06) : 337 - 343
  • [28] Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B
    Peters, MG
    Hann, HW
    Martin, P
    Heathcote, EJ
    Buggisch, P
    Rubin, R
    Bourliere, M
    Kowdley, K
    Trepo, C
    Gray, DF
    Sullivan, M
    Kleber, K
    Ebrahimi, R
    Xiong, S
    Brosgart, CL
    GASTROENTEROLOGY, 2004, 126 (01) : 91 - 101
  • [29] Efficacy of Entecavir in Patients with Chronic Hepatitis B Resistant to Both Lamivudine and Adefovir or to Lamivudine Alone
    Shim, Ju Hyun
    Suh, Dong Jin
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Chung, Young-Hwa
    Lee, Yung Sang
    HEPATOLOGY, 2009, 50 (04) : 1064 - 1071
  • [30] Different mechanism of selection of adefovir-resistant mutant viruses during adefovir monotherapy in patients with lamivudine-resistant chronic hepatitis B
    Cho, Yoo-Kyung
    Cui, Xiu-Ji
    Jeong, Seung Uk
    Song, Byung-Cheol
    ANTIVIRAL RESEARCH, 2014, 112 : 8 - 17
12345